Belmont Global Advisors’s GSK GSK Stock Holding History

Belmont Global Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-12,000	Closed	-$692K	–	105
2015 Q1	$692K	Buy	+12,000	New	+$688K	0.7%	39

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Belmont Global Advisors's GSK Position: Q2 2015 in Review

Belmont Global Advisors sold out of GSK (GSK) in Q2 2015, closing a stake of 12,000 shares — an estimated $692K sold.

Belmont Global Advisors first reported a position in GSK in Q1 2015 and held it in 1 quarter. The position peaked at $692K in Q1 2015. 719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

Belmont Global Advisors reported no remaining GSK position as of Q2 2015 after selling out during the quarter.
Belmont Global Advisors sold 12,000 GSK shares in Q2 2015, an estimated $692K.
Belmont Global Advisors first reported a position in GSK in Q1 2015 and held it in 1 quarter.
Belmont Global Advisors's GSK position peaked at $692K in Q1 2015.
719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Belmont Global Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.